Director, Health Care Senior Analyst
Areas of focus: Health Care
Matt leads RSM’s health care valuation consulting group. In this capacity, Matt helps health care clients evaluate mergers, acquisitions, joint ventures, and other growth strategies.
In January 2018, Matt was selected as a senior analyst RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions impacting middle market leaders. Matt’s focus is on the health care industry.
With the future of health care riding on the outcome of the November elections, RSM analyzed what lies ahead for businesses in the sector.
Even if the boom is leveling off now, we do not expect telehealth use and investments ever to go back to pre-pandemic levels.
COVID-19’s impact and deferral on nonurgent procedures are affecting health care organizations in ways few predicted.
Senior analysts share key takeaways for hospitals and health systems to address the organizational impact of COVID-19.
How are emerging technologies like robotic process automation, artificial intelligence, virtual care and more transforming health care?
What can life sciences businesses do to ensure data protection, especially with their third parties? Get key cybersecurity considerations.
Wearable tech’s transformative power promotes healthy lifestyles, lowers insurance coverage spending and increases employee engagement.
Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.
Life sciences companies must address the growing trove of data as they seek to bring personalized therapies, drugs and devices to market.
Medicaid expansion in 2019 could positively affect health care providers in states with the expanded government benefit.